Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emerging Views On Emerging Markets: The Sanford Bernstein Strategic Decisions Conference

This article was originally published in PharmAsia News

Executive Summary

In this periodic feature, PharmAsia News listens in at major industry events to what senior executives have to say about Asia and other emerging markets. For this profile, we zoom in on the Sanford Bernstein Strategic Decisions Conference, held June 1-2 in New York City.

You may also be interested in...



Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on a recent Sanford Bernstein conference in New York ('Emerging Views On Emerging Markets: The Sanford Bernstein Strategic Decisions Conference,' June 7, 2011). For this profile, we zoom in on the 32nd annual Goldman Sachs Global Healthcare Conference, held June 7-9 in Rancho Palos Verdes, California.

Emerging Views On Emerging Markets: Goldman Sachs Global Healthcare Conference

In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on a recent Sanford Bernstein conference in New York ('Emerging Views On Emerging Markets: The Sanford Bernstein Strategic Decisions Conference,' June 7, 2011). For this profile, we zoom in on the 32nd annual Goldman Sachs Global Healthcare Conference, held June 7-9 in Rancho Palos Verdes, California.

Merck Establishes JV With India's Sun Pharma To Develop Novel Combinations Of Branded Generics For Emerging Markets

MUMBAI - Merck & Co. is establishing a joint venture with India's Sun Pharmaceutical Industries Ltd. for a broad-based alliance to develop, manufacture and commercialize novel combinations and "incrementally innovative" branded generics in emerging markets, the two companies announced April 11

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC078400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel